Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients with Acquired Thrombotic Thrombocytopenic Purpura, PB2249 HemaSphere. 2019 Jun;3(S1):1007. Sargentini L, Hansson E, Bergstrand M, Callewaert F, Sousa RP. HematologyJournalMIDDPharmacometricsSpecial/specific populations Pharmetheus Affiliates Senior Director, Regulatory Affairs Emma Hansson See bio Principal Director, MIDD Scientific Lead Martin Bergstrand See bio
